Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study

SIMPLE SUMMARY: Gemcitabine/nab-paclitaxel (GN) and FOLFIRINOX (FFX) are two standard first-line therapies for metastatic pancreatic cancer (PC) but have rarely been compared, especially in patients with locally advanced PC (LAPC). By carefully selecting patients, it is likely these two regimens lea...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Williet, Nicolas, Petrillo, Angelica, Roth, Gaël, Ghidini, Michele, Petrova, Mila, Forestier, Julien, Lopez, Anthony, Thoor, Audrey, Weislinger, Lucie, De Vita, Ferdinando, Taieb, Julien, Phelip, Jean Marc
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8200096/
https://ncbi.nlm.nih.gov/pubmed/34199796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112797
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados